Galliford Try returns to profit & resumes dividend, Piri increases digital asset investment & Vadim Alexandre on Allergy Therapeutics
Episode 2311, Mar 04, 2021, 01:05 PM
Galliford Try returns to profitability and resumes the dividend. Pires Investment talks about their increase in exposure to digital assets. Vadim Alexandre discusses Allergy Therapeutics.
On the Vox Markets Podcast Today: 4th March 2021
Andrew Duxbury, Finance Director of Galliford Try #GFRD discusses their half year report where they've returned to profitability and have resumed the dividend.
Nick Lee, Investment Director and David Palumbo, Non-Executive Director of Pires Investment #PIRI talks about their increase in exposure to digital assets and other investments.
(Interview starts at 7 minutes 43 seconds)
Vadim Alexandre, Head of Healthcare at SP Angel discusses Allergy Therapeutics #AGY
(Interview starts at 16 minutes 40 seconds)
Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.
#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Investments #Finance #Business #Podcast